Skip to main content
Erschienen in: Supportive Care in Cancer 9/2020

01.09.2020 | Original Article

Factors associated with return to work in breast cancer survivors treated at the Public Cancer Hospital in Brazil

verfasst von: Isabela Caroline Freitas Colombino, Almir José Sarri, Isabela Queiros Castro, Carlos Eduardo Paiva, René Aloisio da Costa Vieira

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the impact of return to work on the quality of life of breast cancer patients and to identify factors related to nonreturn to work.

Methods

An observational, cross-sectional study was performed in breast cancer survivors who had worked before their breast cancer diagnosis. We evaluated factors related to return to work (patient perspective, disease, and work), EORTC quality of life questionnaires (general: EORTC QLQ-C30; and breast cancer-specific: EORTC QLQ-BR23), the Shoulder Pain and Disability Index (SPADI), and the Anxiety and Depression Scale (HADS). Half of the patients underwent a physical therapy examination (shoulder goniometry, hand dynamometry, and limb volume). Univariate and multivariate analysis were performed.

Results

We included 304 patients, 163 of whom underwent physiotherapy evaluation. Approximately 54.0% (164) of the patients returned to work after treatment. The women who returned to work presented lower age, higher education levels, higher incomes, and smaller initial tumor size. The women who returned to work had higher scores related to body image and sexual function, lower scores in relation to disability and pain, and lower scores related to anxiety and depression. In the multivariate model to evaluate nonreturn to work, pretreatment variables were age, education level, and clinical staging. Sequelae related to loss of strength increased the risk of nonreturn to work.

Conclusion

Return to work was influenced by age, education level, previous activity types, axillary treatment, and physical sequelae related to loss of hand strength. Breast cancer treatment decreased the women’s work capacity. Return to work improved the patients’ quality of life.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Damkjaer LH, Deltour I, Suppli NP, Christensen J, Kroman NT, Johansen C, Dalton SO (2011) Breast cancer and early retirement: associations with disease characteristics, treatment, comorbidity, social position and participation in a six-day rehabilitation course in a register-based study in Denmark. Acta Oncol 50(2):274–281. https://doi.org/10.3109/0284186X.2010.531048 CrossRefPubMed Damkjaer LH, Deltour I, Suppli NP, Christensen J, Kroman NT, Johansen C, Dalton SO (2011) Breast cancer and early retirement: associations with disease characteristics, treatment, comorbidity, social position and participation in a six-day rehabilitation course in a register-based study in Denmark. Acta Oncol 50(2):274–281. https://​doi.​org/​10.​3109/​0284186X.​2010.​531048 CrossRefPubMed
7.
Zurück zum Zitat Michels FAS, Latorre M, Maciel MS (2012) Validação e reprodutibilidade do questionário FACT-B+ 4 de qualidade de vida específico para câncer de mama e comparação dos questionários IBCSG, EORTC-BR23 e FACT-B+ 4. Cad Saúde Colet 20(3):321–328 Michels FAS, Latorre M, Maciel MS (2012) Validação e reprodutibilidade do questionário FACT-B+ 4 de qualidade de vida específico para câncer de mama e comparação dos questionários IBCSG, EORTC-BR23 e FACT-B+ 4. Cad Saúde Colet 20(3):321–328
9.
Zurück zum Zitat Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241CrossRef Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241CrossRef
11.
Zurück zum Zitat Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M (2000) Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 39(3):393–397CrossRef Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M (2000) Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 39(3):393–397CrossRef
12.
Zurück zum Zitat Gandini RC (2010) Câncer de mama: consequências da mastectomia na produtividade. Temas em Psicologia 18(2) Gandini RC (2010) Câncer de mama: consequências da mastectomia na produtividade. Temas em Psicologia 18(2)
14.
15.
Zurück zum Zitat Noeres D, Park-Simon TW, Grabow J, Sperlich S, Koch-Giesselmann H, Jaunzeme J, Geyer S (2013) Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Cancer 21(7):1901–1909. https://doi.org/10.1007/s00520-013-1739-1 CrossRefPubMed Noeres D, Park-Simon TW, Grabow J, Sperlich S, Koch-Giesselmann H, Jaunzeme J, Geyer S (2013) Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Cancer 21(7):1901–1909. https://​doi.​org/​10.​1007/​s00520-013-1739-1 CrossRefPubMed
17.
Zurück zum Zitat Johnsson A, Fornander T, Olsson M, Nystedt M, Johansson H, Erik Rutqvist L (2007) Factors associated with return to work after breast cancer treatment. Acta Oncol 46(1):90–96CrossRef Johnsson A, Fornander T, Olsson M, Nystedt M, Johansson H, Erik Rutqvist L (2007) Factors associated with return to work after breast cancer treatment. Acta Oncol 46(1):90–96CrossRef
24.
Zurück zum Zitat Cocchiara RA, Sciarra I, D’Egidio V, Sestili C, Mancino M, Backhaus I, Mannocci A, De Luca A, Frusone F, Di Bella O, Di Murro F, Palmeri V, Lia L, Paradiso G, Aceti V, Libia A, Monti M, La Torre G (2018) Returning to work after breast cancer: a systematic review of reviews. Work 61(3):463–476. https://doi.org/10.3233/WOR-182810 CrossRefPubMed Cocchiara RA, Sciarra I, D’Egidio V, Sestili C, Mancino M, Backhaus I, Mannocci A, De Luca A, Frusone F, Di Bella O, Di Murro F, Palmeri V, Lia L, Paradiso G, Aceti V, Libia A, Monti M, La Torre G (2018) Returning to work after breast cancer: a systematic review of reviews. Work 61(3):463–476. https://​doi.​org/​10.​3233/​WOR-182810 CrossRefPubMed
27.
Zurück zum Zitat Batiston AP, Santiago SM (2005) Fisioterapia e complicações físico-funcionais após tratamento cirúrgico do câncer de mama. Fisioterapia e pesquisa 12(3):30–35 Batiston AP, Santiago SM (2005) Fisioterapia e complicações físico-funcionais após tratamento cirúrgico do câncer de mama. Fisioterapia e pesquisa 12(3):30–35
28.
Zurück zum Zitat Peressim L, Monteiro M (2012) Retorno ao trabalho de mulheres sobreviventes de câncer de mama: fators intervenientes. Universidade de Campinas, Campinas Peressim L, Monteiro M (2012) Retorno ao trabalho de mulheres sobreviventes de câncer de mama: fators intervenientes. Universidade de Campinas, Campinas
30.
Zurück zum Zitat de Souza CN, Zomkowski K, Fernandes BL, Sacomori C, de Azevedo Guimaraes AC, Sperandio FF (2019) Physical symptoms and components of labor tasks associated with upper limb disability among working breast cancer survivors. Breast Cancer:1–7. https://doi.org/10.1007/s12282-019-01004-y de Souza CN, Zomkowski K, Fernandes BL, Sacomori C, de Azevedo Guimaraes AC, Sperandio FF (2019) Physical symptoms and components of labor tasks associated with upper limb disability among working breast cancer survivors. Breast Cancer:1–7. https://​doi.​org/​10.​1007/​s12282-019-01004-y
31.
Zurück zum Zitat Martins J, Napoles BV, Hoffman CB, Oliveira AS (2010) The Brazilian version of Shoulder Pain and Disability Index: translation, cultural adaptation and reliability. Rev Bras Fis 14(6):527–536CrossRef Martins J, Napoles BV, Hoffman CB, Oliveira AS (2010) The Brazilian version of Shoulder Pain and Disability Index: translation, cultural adaptation and reliability. Rev Bras Fis 14(6):527–536CrossRef
34.
Zurück zum Zitat Marcolino JAM, Mathias LAST, Piccinini-Filho L, Guaratini AA, Suzuki FM, Alli LAC (2007) Hospital Anxiety and Depression Scale: a study on the validation of the criteria and reliability on preoperative patients. Rev Bras Anestesiol 57(1):52–62CrossRef Marcolino JAM, Mathias LAST, Piccinini-Filho L, Guaratini AA, Suzuki FM, Alli LAC (2007) Hospital Anxiety and Depression Scale: a study on the validation of the criteria and reliability on preoperative patients. Rev Bras Anestesiol 57(1):52–62CrossRef
39.
Zurück zum Zitat Carlsen K, Ewertz M, Dalton SO, Badsberg JH, Osler M (2014) Unemployment among breast cancer survivors. Scand J Public Health 42(3):319–328CrossRef Carlsen K, Ewertz M, Dalton SO, Badsberg JH, Osler M (2014) Unemployment among breast cancer survivors. Scand J Public Health 42(3):319–328CrossRef
43.
Zurück zum Zitat Lofland JH, Pizzi L, Frick KD (2004) A review of health-related workplace productivity loss instruments. Pharmacoeconomics 22(3):165–184CrossRef Lofland JH, Pizzi L, Frick KD (2004) A review of health-related workplace productivity loss instruments. Pharmacoeconomics 22(3):165–184CrossRef
44.
Zurück zum Zitat Landeiro L, Mano M (2017) Retorno ao trabalho em pacientes com câncer de mama tratadas em um serviço oncológico do Sistema Único de Saúde (SUS). Universidade de São Paulo, São Paulo Landeiro L, Mano M (2017) Retorno ao trabalho em pacientes com câncer de mama tratadas em um serviço oncológico do Sistema Único de Saúde (SUS). Universidade de São Paulo, São Paulo
47.
Zurück zum Zitat Vieira RAC, Formenton A, Bertolini SR (2017) Breast cancer screening in Brazil. Barriers related to the health system. Rev Assoc Med Bras (1992) 63(5):470–478CrossRef Vieira RAC, Formenton A, Bertolini SR (2017) Breast cancer screening in Brazil. Barriers related to the health system. Rev Assoc Med Bras (1992) 63(5):470–478CrossRef
Metadaten
Titel
Factors associated with return to work in breast cancer survivors treated at the Public Cancer Hospital in Brazil
verfasst von
Isabela Caroline Freitas Colombino
Almir José Sarri
Isabela Queiros Castro
Carlos Eduardo Paiva
René Aloisio da Costa Vieira
Publikationsdatum
01.09.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05164-7

Weitere Artikel der Ausgabe 9/2020

Supportive Care in Cancer 9/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.